RECRUITING

Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones

Description

This study tests whether hydroxycitrate, a molecule closely related to citrate, can reduce calcium phosphate stone recurrence.

Study Overview

Study Details

Study overview

This study tests whether hydroxycitrate, a molecule closely related to citrate, can reduce calcium phosphate stone recurrence.

Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones

Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones

Condition
Calcium Phosphate Kidney Stones
Intervention / Treatment

-

Contacts and Locations

Dallas

UT Southwestern Medical Center, Dallas, Texas, United States, 75390-8885

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * History of recurrent urinary tract infections
  • * Chronic diarrhea
  • * Estimated Glomerular Filtration Rate (eGFR) \< 45 ml/min/1.73 m2
  • * History of primary hyperparathyroidism
  • * Hypokalemia
  • * Hyperkalemia
  • * Pregnancy

Ages Eligible for Study

21 Years to 99 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Texas Southwestern Medical Center,

NAIM M MAALOUF, PRINCIPAL_INVESTIGATOR, University of Texas Southwestern Medical Center

Study Record Dates

2028-08-31